PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-70.63%
Negative net income growth while MRVL stands at 20.37%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-1.29%
Negative yoy D&A while MRVL is 0.10%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-12.20%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-23.03%
Both reduce yoy usage, with MRVL at -11250.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-75.28%
Both reduce yoy inventory, with MRVL at -3615.38%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-10.79%
Both reduce yoy usage, with MRVL at -750.37%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
102.19%
Growth of 102.19% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
-34.43%
Both yoy CFO lines are negative, with MRVL at -26.06%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
26.20%
Some CapEx rise while MRVL is negative at -25.83%. John Neff would see competitor possibly building capacity while we hold back expansions.
100.00%
Acquisition growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
56.46%
Some yoy expansion while MRVL is negative at -54.40%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
30.23%
Liquidation growth of 30.23% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-100.00%
We reduce yoy other investing while MRVL is 274.10%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-34.55%
We reduce yoy invests while MRVL stands at 270.61%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-35.04%
Both yoy lines negative, with MRVL at -55.14%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-63.45%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.